圣诺生物：2025年净利润同比预增204.42%—280.53%

Core Viewpoint - Shengnuo Bio (688117) expects to achieve a net profit attributable to shareholders of the parent company between 152 million and 190 million yuan for the fiscal year 2025, representing a year-on-year increase of 204.42% to 280.53% [1] Group 1 - The company is focusing on its annual business strategy while advancing the construction of its production capacity [1] - There is a continuous expansion of both domestic and international markets, leading to sustained growth in demand for the company's peptide raw material business [1]